1448874-96-1Relevant articles and documents
SOLID FORMS OF (Z)-METHYL 3-(((4-(N-METHYL-2-(4-METHYLPIPERAZIN-L- YL)ACETAMIDO)PHENYL)AMINO)(PHENYL)METHYLENE)-2-OXO-2, 3-DIHYDRO- LH-PYRROLO[2,3-B]PYRIDINE-6-CARBOXYLATE AND SALTS THEREOF
-
, (2022/01/12)
The present disclosure provides crystalline solid forms of an antifibrotic agent, pharmaceutical compositions comprising the same, and methods of use thereof.
ANTIFIBROTIC COMPOUNDS AND USES THEREOF
-
, (2015/11/16)
The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions ther
ANTIFIBROTIC COMPOUNDS AND USES THEREOF
-
Paragraph 000159, (2013/08/15)
The present invention provides compounds having the general structural formula (I), and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving abnormal or excessive fibrosis.